Page last updated: 2024-11-03

proglumide and Hormone-Dependent Neoplasms

proglumide has been researched along with Hormone-Dependent Neoplasms in 1 studies

Proglumide: A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
proglumide : A racemate composed of equal amounts of (R)- and (S)-proglumide. A non-selective CCK antagonist that was used primarily for treatment of stomach ulcers, but has been replaced by newer drugs.
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-benzoylglutamic acid with dippropylamine.

Research Excerpts

ExcerptRelevanceReference
"The effects of gastrin, proglumide (a gastrin receptor antagonist), and somatostatin on growth of human colon adenocarcinoma cell lines CX1, X56, and HT29 were examined in two experimental models."3.67Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. ( Smith, JP; Solomon, TE, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, JP1
Solomon, TE1

Other Studies

1 other study available for proglumide and Hormone-Dependent Neoplasms

ArticleYear
Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer.
    Gastroenterology, 1988, Volume: 95, Issue:6

    Topics: Adenocarcinoma; Animals; Cell Line; Colonic Neoplasms; DNA, Neoplasm; Gastrins; Glutamine; Humans; M

1988